Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 February, 2018 15:58 IST
Divis Lab receives import alert for Visakhapatnam facility
Source: IRIS | 21 Mar, 2017, 10.10AM
Comments  |  Post Comment

Divis Laboratories, a pharmaceutical ingredients and intermediates company, has received an Import Alert 66-40 from US Food and Drug Administration (USFDA) for its products manufactured at the company's Unit-II located at Visakhapatnam, Andhra Pradesh on March 20, 2017.

The agency has exempted the following products from the Import Alert-Levetiracetam, Gabapentin, Lamotrigine, Capecitabine, Naproxen sodium, Raltegravir potassium, Atovaquone, Chloropurine, BOC core succinate, 2, 4-wing active ester.

The company along with third party consultants is currently working to address the concerns of the USFDA and is making all efforts to fully meet the compliance requirements. 

Shares of the company declined Rs 138.7, or 17.54%, to trade at Rs 652.00. The total volume of shares traded was 1,228,420 at the BSE (10.02 a.m., Tuesday).



Divis Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
MCX enhances maximum compensation limit to Rs 2.5 mn - 23-Feb-2018 10:31
Reliance Infra wins EPC contract worth Rs 36.47 bn - 23-Feb-2018 10:04
Larsen & Toubro bags orders worth Rs 12.66 bn - 23-Feb-2018 09:33
Vascon Engineers inks deal with Lina Ashar Foundation - 22-Feb-2018 13:15
Tata Comm partners with Taiwan's Chunghwa Telecom - 22-Feb-2018 10:57
Godrej Properties adds new residential project in Gurgaon - 22-Feb-2018 10:22
Indian Hume Pipe Co secures work order worth Rs 1.35 bn - 22-Feb-2018 10:15
Glenmark Pharma enters into collaboration with SDC Pharma - 22-Feb-2018 09:39
Lupin launches generic Namenda XR capsules in US - 21-Feb-2018 16:00
Lupin gets USFDA nod for generic Tamiflu for oral suspension - 21-Feb-2018 14:27
SSWL wins exports order from German OEM-BMW - 21-Feb-2018 12:15
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer